Genetic Technologies Limited operates in the Medical laboratories sector. In addition to historical fundamental analyses, the complete report available to purchase compares Genetic Technologies Limited with three other pharmaceutical manufacturers in Australasia: Rhythm Biosciences Ltd (2020 sales of 46,266.00 Australian Dollars [US$35,644.25 ] ), Prescient Therapeutics Ltd (70,361.00 Australian Dollars [US$54,207.52 ] of which 100% was Clinical stage oncology), and Alterity Therapeutics Ltd (17,117.00 Australian Dollars [US$13,187.28 ] of which 100% was Reaserch and development in the field of).

Sales Analysis. Sales were up sharply during the second fiscal quarter of 2021 versus the previous year's second quarter. During the second fiscal quarter of 2021, sales at Genetic Technologies Limited totalled A$16,436.00 . This is an increase of 2,704.8% from the A$586.00 in sales at the company during the second quarter of 2020. Genetic Technologies Limited reported sales of A$9,864.00 (US$7.60 thousand) for the fiscal year ending June of 2020. This represents a sharp decrease of 61.2% versus 2019, when the company's sales were A$25,444.00 .